Caret and Retinol Efficacy Trial: The Caret Coordinating Center
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Lung Cancer Incidence
bi-annual
Yes
Gary E Goodman, MD
Principal Investigator
Fred Hutchinson Cancer Research Center
United States: Food and Drug Administration
FHCRC IR-4239A
NCT00712647
May 1985
June 2005
Name | Location |
---|